Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04724252 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 8 words
    • Site contact updated
    v9
  2. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v8
  3. Primary completion date: Jan 31, 2023 to Dec 31, 2024
    • Study completion date: Jan 31, 2024 to Dec 31, 2024
    • Site contact updated
    v7
  4. Study Status, Referencesv6
  5. Start date changed from estimate of May 17, 2021 to Aug 23, 2021v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: May 31, 2021 to May 17, 2021v4
  2. Start date: Mar 31, 2021 to May 31, 2021v3
  3. Start date: Jan 31, 2021 to Mar 31, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin
Trial Details
NCT Number NCT04724252
Lead Sponsor University of California, Davis
Conditions
(from sponsor)		 Pain, Postoperative
Related terms Postoperative Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov